What the business is, and whether it's a good one at a fair price.
Operates a network of diagnostic centres across Delhi, Uttar Pradesh and Nashik, offering MRI, CT, ultrasound, X-ray and pathology services under a single Diagnostic Services segment. FY26 revenue of INR88.5 crores was split across three channels: business-to-government (B2G) at INR47.3 crores via empanelment with bodies such as BIS, IPGCL, NIEPA, INSA, the High Court of Delhi, CERC and ICSSR, billed at CGHS rates; business-to-consumer (B2C) at INR33 crores from walk-in patients; and business-to-business (B2B) at INR8.1 crores through hospital tie-ups. B2C grew 18% in FY26, B2B grew about 10%, while B2G was stable. The company invests in advanced imaging equipment — including what it claims is North India's first 1184 slice/sec CT scanner at Tilak Nagar — and is opening a new Dwarka centre. Other operating expenses are the largest cost line at 47% of revenue, with employee cost at 9.1% and capex at 11.6% of revenue. Government receivables of INR49.9 crores run on a 6-month payment cycle, a notable working-capital feature of the model.
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from STAR IMAGING AND PATH LAB LIMI's filed financials and exchange disclosures
STAR IMAGING AND PATH LAB LIMI is a Healthcare Services company listed on BSE.
Effectively yes. It holds ₹22 Cr more cash than debt.
On trailing P/E, STAR IMAGING AND PATH LAB LIMI ranks 6 of 29 in Healthcare Service Provider — cheaper than 82% of them, against an industry median of 23.2×. This is a position, not a valuation judgement.
On a typical session STAR IMAGING AND PATH LAB LIMI moves 2.31% — that is the median absolute close-to-close move across its last 263 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by STAR IMAGING AND PATH LAB LIMI appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
